Evidence map›Paper›PMID 30054579›Full record

ArticleScientific reports2018

Streptozotocin-induced β-cell damage, high fat diet, and metformin administration regulate Hes3 expression in the adult mouse brain.

Polyxeni Nikolakopoulou, Antonios Chatzigeorgiou, Ioannis Kourtzelis, Louiza Toutouna, Jimmy Masjkur, Carina Arps-Forker, Steven W Poser, Jan Rozman, Birgit Rathkolb, Juan Antonio Aguilar-Pimentel and 19 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Pathological effects of diabetic mice withWorld journal of diabetes · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 13 institutions in 6 countries.

Polyxeni NikolakopoulouDepartment of Medicine, Technische Universität Dresden, Dresden, Germany.
Antonios ChatzigeorgiouDepartment of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, Dresden, Germany.
Ioannis KourtzelisDepartment of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, Dresden, Germany.
Louiza ToutounaDepartment of Medicine, Technische Universität Dresden, Dresden, Germany.
Jimmy MasjkurDepartment of Medicine, Technische Universität Dresden, Dresden, Germany.
Carina Arps-ForkerDepartment of Medicine, Technische Universität Dresden, Dresden, Germany.
Steven W PoserDepartment of Medicine, Technische Universität Dresden, Dresden, Germany.
Jan RozmanGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.ORCID 0000-0002-8035-8904
Birgit RathkolbGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.
Juan Antonio Aguilar-PimentelGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.ORCID 0000-0002-4694-7107
German Mouse Clinic Consortium
Eckhard WolfInstitute of Molecular Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilians-University Munich, Feodor-Lynen Str. 25, 81377, Munich, Germany.
Martin KlingensporChair of Molecular Nutritional Medicine, Technical University Munich, EKFZ - Else Kröner Fresenius Center for Nutritional Medicine, Gregor-Mendel-Str. 2, 85350, Freising-Weihenstephan, Germany.
Markus OllertDepartment of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Carsten Schmidt-WeberCenter of Allergy & Environment (ZAUM), Technische Universität München, and Helmholtz Zentrum München, Ingolstädter Landstr.1, 85764, Neuherberg, Germany.
Helmut FuchsGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.ORCID 0000-0002-5143-2677
Valerie Gailus-DurnerGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.
Martin Hrabe de AngelisGerman Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.ORCID 0000-0002-7898-2353
Vasiliki TsataDFG-Center for Regenerative Therapies Dresden, Cluster of Excellence, Technische Universität Dresden, Dresden, Germany.
Laura Sebastian MonasorDepartment of Medicine, Technische Universität Dresden, Dresden, Germany.
Maria TroullinakiDepartment of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, Dresden, Germany.
Anke WittDepartment of Clinical Pathobiochemistry, Institute for Clinical Chemistry and Laboratory Medicine, Dresden, Germany.
Vivian AnastasiouDZD/Paul Langerhans Institute Dresden of Helmholtz Centre Munich, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
George ChrousosFirst Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Athens, Greece.
Chun-Xia YiDepartment of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Cristina García-CáceresHelmholtz Diabetes Center (HDC) & German Center for Diabetes Research (DZD), Helmholtz Zentrum München, 85764, Neuherberg, Germany.
Matthias H TschöpHelmholtz Diabetes Center (HDC) & German Center for Diabetes Research (DZD), Helmholtz Zentrum München, 85764, Neuherberg, Germany.
Stefan R BornsteinDepartment of Medicine, Technische Universität Dresden, Dresden, Germany.
Andreas Androutsellis-TheotokisDepartment of Medicine, Technische Universität Dresden, Dresden, Germany. andreas.theotokis@uniklinikum-dresden.de.
Helmholtz Zentrum München · DETechnische Universität Dresden · DEGerman Center for Neurodegenerative Diseases · DEAmsterdam UMC Location University of Amsterdam · NLHeidelberg University · DEInstitute of Medical Microbiology and Hygiene · DELudwig-Maximilians-Universität München · DENational and Kapodistrian University of Athens · GRPaul Langerhans Institute Dresden · DEUniversity of Bonn · DEUniversity of Nottingham · GBUniversity of Southern Denmark · DKWeihenstephan-Triesdorf University of Applied Sciences · DE

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) SFB655, Project A24
6 · The paper itself

Abstract

Diabetes mellitus is a group of disorders characterized by prolonged high levels of circulating blood glucose. Type 1 diabetes is caused by decreased insulin production in the pancreas whereas type 2 diabetes may develop due to obesity and lack of exercise; it begins with insulin resistance whereby cells fail to respond properly to insulin and it may also progress to decreased insulin levels. The brain is an important target for insulin, and there is great interest in understanding how diabetes affects the brain. In addition to the direct effects of insulin on the brain, diabetes may also impact the brain through modulation of the inflammatory system. Here we investigate how perturbation of circulating insulin levels affects the expression of Hes3, a transcription factor expressed in neural stem and progenitor cells that is involved in tissue regeneration. Our data show that streptozotocin-induced β-cell damage, high fat diet, as well as metformin, a common type 2 diabetes medication, regulate Hes3 levels in the brain. This work suggests that Hes3 is a valuable biomarker helping to monitor the state of endogenous neural stem and progenitor cells in the context of diabetes mellitus.

Indexed as

Diet, High-FatAgingAnimalsBasic Helix-Loop-Helix ProteinsBrainGene Expression RegulationInsulin-Secreting CellsMaleMetforminMice, Inbred C57BLNerve Tissue ProteinsPhenotypeRepressor ProteinsStreptozocinBasic Helix-Loop-Helix ProteinsHes3 protein, mouseMetforminNerve Tissue ProteinsRepressor ProteinsStreptozocin

Identifiers

PMID30054579
PMCPMC6063949
OpenAlexW2883536570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.